Randomized Trial of Lisinopril (cas 76547-98-3) Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
-
Add time:07/11/2019 Source:sciencedirect.com
BackgroundTrastuzumab is highly effective for human epidermal growth factor receptor type 2 (HER2)–positive breast cancer but is associated with a decline in left ventricular ejection fraction.
We also recommend Trading Suppliers and Manufacturers of Lisinopril (cas 76547-98-3). Pls Click Website Link as below: cas 76547-98-3 suppliers
Prev:CdS nanocrystals as fluorescent probe for detection of Dolasetron mesylate (cas 115956-13-3) in aqueous solution: Application to biomedical analysis
Next:Lisinopril (cas 76547-98-3) inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of Lisinopril (cas 76547-98-3) vs. perindopril: A cohort study07/19/2019
- Fast and sensitive LC–MS/MS method for the simultaneous determination of Lisinopril (cas 76547-98-3) and hydrochlorothiazide in human plasma07/18/2019
- Development and characterization of sublingual tablet of Lisinopril (cas 76547-98-3)07/17/2019
- Daily Lisinopril (cas 76547-98-3) vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial07/16/2019
- The cough reflex is upregulated by Lisinopril (cas 76547-98-3) microinjected into the caudal nucleus tractus solitarii of the rabbit07/15/2019
- An innovative validated spectrofluorimetric method for determination of Lisinopril (cas 76547-98-3) in presence of hydrochlorothiazide; application to content uniformity testing07/14/2019
- Effect of amlodipine, Lisinopril (cas 76547-98-3) and allopurinol on acetaminophen-induced hepatotoxicity in rats07/13/2019
- Lisinopril (cas 76547-98-3) inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis07/12/2019